Skip to search boxSkip to navigationSkip to main content

A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype

  • Veronica Porterfield
    ,
  • Shahzad S. Khan
    ,
  • Erin P. Foff
    ,
  • Mehmet Murat Koseoglu
    ,
  • Isabella K. Blanco
    ,
  • Sruthi Jayaraman
*Corresponding author for this work
  • University of Virginia
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

A hexanucleotide repeat expansion on chromosome 9 open reading frame 72 (C9orf72) is associated with familial amyotrophic lateral sclerosis (ALS) and a subpopulation of patients with sporadic ALS and frontotemporal dementia. We used inducible pluripotent stem cells from neurotypic and C9orf72+ (C9+) ALS patients to derive neuronal progenitor cells. We demonstrated that C9+ and neurotypic neuronal progenitor cells differentiate into neurons. The C9+ neurons, however, spontaneously re-expressed cyclin D1 after 12 weeks, suggesting cell cycle re-engagement. Gene profiling revealed significant increases in senescence-associated genes in C9+ neurons. Moreover, C9+ neurons expressed high levels of mRNA for CXCL8, a chemokine overexpressed by senescent cells, while media from C9+ neurons contained significant levels of CXCL8, CXCL1, IL13, IP10, CX3CL1, and reactive oxygen species, which are components of the senescence-associated secretory phenotype. Thus, re-engagement of cell cycle-associated proteins and a senescence-associated secretory phenotype could be fundamental components of neuronal dysfunction in ALS and frontotemporal dementia.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 125-134 (10 pages)

Journal (Volume, Issue Number)

Neurobiology of Aging (Volume 90)

Publication milestones

  • Published - 06/2020

Publication status

Published - 06/2020

ISSN

0197-4580

Publication IDs

  • Scopus: 85081655584
  • PubMed: 32184029

Publication metrics

Metrics

Scopus
citations
SciVal
citations
1
SciVal
FWCI
0.41
SciVal
Author count
11
SciVal
Paper percentile
67
Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
15
Mentions
1
Captures
44

Funding Details

The work was supported by grants from the Fiske Drug Discovery Fund (JSL, ERS), the Owens Family Foundation (EPF, JSL, GSB), NIH RF1 AG51085 (GSB), NIH R01 AG063400 (ERS), Hartwell Foundation (EPF), and the Cure Alzheimer’s Fund (GSB, JSL ERS). This work used the Zeiss 710 Confocal Microscope in the Advanced Microscopy Facility, the Luminex MagPix in the Flow Cytometry Core, and neural progenitor cells produced by the Stem Cell Core Facility, which are all facilities supported by the University of Virginia School of Medicine. We also thank the Cedars-Sinai Medical Center’s David and Janet Polak Foundation Stem Cell Core Laboratory for the ALS C9+ iPS cells. This manuscript is dedicated to the memory of James F. Capps (1958–2015). The work was supported by grants from the Fiske Drug Discovery Fund (JSL, ERS), the Owens Family Foundation (EPF, JSL, GSB), NIH RF1 AG51085 (GSB), NIH R01 AG063400 (ERS), Hartwell Foundation (EPF), and the Cure Alzheimer's Fund (GSB, JSL ERS). This work used the Zeiss 710 Confocal Microscope in the Advanced Microscopy Facility, the Luminex MagPix in the Flow Cytometry Core, and neural progenitor cells produced by the Stem Cell Core Facility, which are all facilities supported by the University of Virginia School of Medicine. We also thank the Cedars-Sinai Medical Center's David and Janet Polak Foundation Stem Cell Core Laboratory for the ALS C9+ iPS cells. This manuscript is dedicated to the memory of James F. Capps (1958–2015).
FundersFunding numbers
EPF
-
Fiske Drug Discovery Fund
-
NIH
R01 AG063400
NIA
RF1AG051085
Hartwell Foundation
-
CAF
-
CS
-
UVA SoM
-
Owens Family Foundation
-